1. Biotechnology

Ipsen's hopes for next-gen rare disease drug dashed by pivotal phase 2 fail

Written by Posted on Less than 0 min read

Ipsen’s oral small molecule failed to reduce the progression of a genetic disease that gradually turns tendons and ligaments into bone, prompting the pharma to stop the study early.

Member since

More from Admin

Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Pollinators most vulnerable to rising global temperatures are flies, study shows

Despite their reputation as buzzing nuisances, flies serve a critical role as some of the Earth’s most prolific pollinators — and new research led by Penn State scientists suggests they are increasingly at risk due to rising global temperatures. In a study recently published in the Journal of Melittology, an international team of researchers looked […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Hijacking the command center of the cell: Nuclear parasites in deep-sea mussels

Most animals live in intimate relationships with bacteria. Some of these bacteria live inside the cells of their hosts, but only very few are able to live inside cell organelles (structures inside the cell, like organs in the body). One group of bacteria have figured out how to colonize the nuclei of their hosts, a […]
Written by
A volcano erased an island’s plants. Their DNA revealed how life starts over
  1. Life Sciences

A volcano erased an island’s plants. Their DNA revealed how life starts over

Scientists from Tokyo Metropolitan University have determined the genetic lineage of a now extinct plant population from Nishinoshima, a volcanic island whose frequent eruptions periodically “reset” the vegetation. While they traced the lineage to a nearby island, they discovered distinct genetic quirks due to the rarity of seeds making it there, including a “founder’s effect.” […]
Written by
A traditional Brazilian plant shows unexpected strength against arthritis
  1. Life Sciences

A traditional Brazilian plant shows unexpected strength against arthritis

A research team in Brazil has found strong evidence that the Joseph’s Coat plant (Alternanthera littoralis) is both safe and effective at reducing inflammation, easing pain, and protecting against arthritis. The study was carried out by scientists from the Federal University of Grande Dourados (UFGD), the State University of Campinas (UNICAMP), and São Paulo State […]
Written by
Can these endangered lizards beat the heat? Scientists test bold relocation plan
  1. Life Sciences

Can these endangered lizards beat the heat? Scientists test bold relocation plan

Climate change and habitat loss are affecting animal populations around the world and reptiles such as South Australia’s own endangered pygmy bluetongue are susceptible to higher temperatures and declining long-term rainfall trends. Flinders University scientists are working on securing a sustainable future for the burrow-dwelling endemic skink (Tiliqua adelaidensis) by assessing their suitability to cooler […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

As we age, our cells are much less prone to specific longer genes

Ageing could also be much less about particular “ageing genes” and extra about how lengthy a gene is. Lots of the adjustments related to ageing may very well be occurring as a result of decreased expression of lengthy genes, say researchers in an opinion piece publishing March 21 within the journal Tendencies in Genetics. A […]
Written by
Scientists warn of bat virus just one mutation from infecting humans
  1. Life Sciences

Scientists warn of bat virus just one mutation from infecting humans

A group of bat viruses closely related to the deadly Middle East respiratory syndrome coronavirus (MERS-CoV) could be one small mutation away from being capable of spilling over into human populations and potentially causing the next pandemic. A recent study published in the journal Nature Communicationsexamined an understudied group of coronaviruses known as merbecoviruses — […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Elephants on the move: Mapping connections across African landscapes

Elephant conservation is a major priority in southern Africa, but habitat loss and urbanization mean the far-ranging pachyderms are increasingly restricted to protected areas like game reserves. The risk? Contained populations could become genetically isolated over time, making elephants more vulnerable to disease and environmental change. A recent study from the University of Illinois Urbana-Champaign […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Eating an array of smaller fish could be nutrient-dense solution to overfishing

To satisfy the seafood needs of billions of people, offering them access to a more biodiverse array of fish creates opportunities to mix-and-match species to obtain better nutrition from smaller portions of fish. The right combination of certain species can provide up to 60% more nutrients than if someone ate the same quantity of even […]
Written by
Archaeologists uncover lost land bridge that may rewrite human history
  1. Life Sciences

Archaeologists uncover lost land bridge that may rewrite human history

Once connected stretches of land, now hidden beneath the sea, may have given early humans a way to move between what is today Türkiye and Europe, according to groundbreaking new research in this little-studied region. The study, recently published in the peer-reviewed Journal of Island and Coastal Archaeology, reveals the first evidence of Paleolithic activity […]
Written by
Scientists finally read the hidden DNA code that shapes disease
  1. Life Sciences

Scientists finally read the hidden DNA code that shapes disease

For centuries, scientists have noticed that certain illnesses seem to pass from one generation to the next, a connection first noted by Hippocrates, who observed that some diseases “ran in families.” Over time, researchers have steadily advanced their ability to uncover the biological roots of these inherited patterns within the human genome. A team of […]
Written by
  1. Biology

Functionally conserved inner mitochondrial membrane proteins CCDC51 and Mdm33 demarcate a subset of fission events

While extensive work has examined the mechanisms of mitochondrial fission, it remains unclear whether internal mitochondrial proteins in metazoans play a direct role in the process. Previously, the yeast inner membrane protein Mdm33 was shown to be required for normal mitochondrial morphology and has been hypothesized to be involved in mitochondrial fission. However, it is […]
Written by
  1. Biology

How do trypanosome IFT trains choose special tracks?

Intraflagellar transport trains in Trypanosoma brucei are known to selectively associate with a subset of axonemal doublet microtubules. In this issue, Araujo Alves et al. (https://doi.org/10.1083/jcb.202501088) aim to elucidate the mechanisms underlying this selective association using high-resolution microscopy approaches. Admin Member since October 11, 2023 Loading + Follow Following
Written by
  1. Biology

Researchers from Tel Aviv University have for the first time created a

Researchers from Tel Aviv University (TAU) have created a new type of glass with unique and even contradictory properties, such as being a strong adhesive (sticky) and incredibly transparent at the same time. The glass, which forms spontaneously when comes in contact with water at room temperature, could bring about a revolution in an array […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Allergan Aesthetics Announces Positive Topline Results from Two Pivotal Phase 3 Studies of TrenibotulinumtoxinE (BoNT/E) for the Treatment of Glabellar Lines

IRVINE, Calif., Oct. 24, 2023 /PRNewswire/ — Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced positive topline results from two pivotal Phase 3 clinical studies evaluating trenibotulinumtoxinE (BoNT/E) for the treatment of moderate to severe glabellar lines (M21-500 and M21-508). The Phase 3 multicenter, randomized, double-blind, placebo-controlled studies evaluated the safety and efficacy of […]
Written by
  1. Clinical

Unlocking the Benefits: Understanding Clinical Studies That Pay

Clinical studies that pay are research studies conducted by pharmaceutical companies or other organizations to evaluate the safety and effectiveness of new drugs, treatments, or medical devices. These studies recruit volunteers who are willing to participate in the research and compensate them financially for their time and participation. While some people may have reservations about […]
Written by
  1. Clinical

AskBio receives FDA Fast Track and MHRA Innovation Passport Designations for AB-1005 Investigational GDNF Gene Therapy for Parkinson’s Disease

Berlin, Germany, and Research Triangle Park, N.C., USA, July 11, 2024 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track Designation for AB-1005, which is […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Omvoh (mirikizumab-mrkz), a First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis

FDA Approves Omvoh (mirikizumab-mrkz), a First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis INDIANAPOLIS, Oct. 26, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh™ (mirikizumab-mrkz) infusion (300 mg/15 mL)/injection (100 mg/mL), the first and only interleukin-23p19 (IL-23p19) antagonist […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: Ipsen's hopes for next-gen rare disease drug dashed by pivotal phase 2 fail

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.